Definition
A nerve biopsy is a surgical procedure in which a small segment of peripheral nerve tissue is removed for microscopic examination. The primary purpose is to obtain histopathological information that aids in the diagnosis of peripheral neuropathies, neuromuscular disorders, and certain systemic diseases that affect nerve tissue.
Indications
Common clinical indications for nerve biopsy include:
| Category | Specific Conditions |
|---|---|
| Inflammatory neuropathies | Chronic inflammatory demyelinating polyneuropathy (CIDP), vasculitic neuropathy, sarcoidosis, lupus erythematosus |
| Infectious neuropathies | Leprosy (Hansen disease), Lyme disease, HIV‑associated neuropathy |
| Metabolic/degenerative disorders | Amyloid neuropathy, Fabry disease, diabetic neuropathy (selected cases) |
| Neoplastic processes | Neurolymphomatosis, nerve sheath tumors (e.g., schwannoma, neurofibroma) |
| Unknown etiology | Chronic progressive neuropathies where non‑invasive testing is inconclusive |
Guidelines generally recommend nerve biopsy when the result is likely to alter management and when less invasive modalities (e.g., serology, imaging, nerve conduction studies) have not yielded a definitive diagnosis.
Commonly Biopsied Nerves
The sural nerve is the most frequently selected site because it is superficial, contains primarily sensory fibers, and its removal typically results in a limited sensory deficit. Other nerves occasionally biopsied include:
- Superficial peroneal nerve
- Superficial radial nerve
- Superficial branch of the ulnar nerve (rare)
Selection depends on the distribution of clinical symptoms, accessibility, and the desire to minimize functional loss.
Procedure
- Pre‑operative assessment – Includes detailed neurological examination, electrophysiological studies, and imaging to localize the affected nerve segment.
- Anesthesia – Usually performed under local anesthesia with or without sedation; general anesthesia may be used for pediatric or uncooperative patients.
- Surgical technique – A small skin incision (1–2 cm) is made over the chosen nerve. The nerve is identified, isolated, and a 2–5 mm segment is excised. Hemostasis is achieved, and the wound is closed in layers.
- Specimen handling – The tissue is promptly fixed (typically in glutaraldehyde for electron microscopy or formalin for routine light microscopy) and sent to a pathology laboratory equipped for neuropathology.
Histopathological Evaluation
Biopsy specimens are examined using a combination of techniques:
- Light microscopy with routine stains (H&E, Luxol fast blue) to assess myelin and axonal integrity.
- Immunohistochemistry to detect inflammatory cells (CD3, CD20), endothelial markers, and specific protein deposits (e.g., amyloid, glucocerebrosidase).
- Electron microscopy for ultra‑structural analysis of myelin lamellae, axonal organelles, and deposition of abnormal substances.
- Specialized stains (e.g., Congo red for amyloid, PAS for glycogen) when indicated.
Findings may reveal demyelination, axonal degeneration, vasculitis, granulomatous inflammation, infectious organisms, or neoplastic infiltration, providing diagnostic clarification.
Complications and Risks
While generally safe, nerve biopsy carries potential adverse effects:
| Complication | Frequency (approx.) |
|---|---|
| Sensory loss at the donor site | 5–10 % (usually mild and permanent) |
| Neuropathic pain or dysesthesia | 2–5 % |
| Wound infection | <1 % |
| Hematoma | <1 % |
| Neuroma formation | Rare |
Meticulous surgical technique and appropriate patient selection mitigate these risks.
Limitations
- Sampling error – Focal or segmental pathology may be missed if the biopsy does not capture the affected segment.
- Interpretive expertise – Accurate diagnosis requires neuropathologists experienced in peripheral nerve disease.
- Alternative diagnostics – Advances in imaging (high‑resolution MRI, nerve ultrasound), serological testing, and genetic sequencing may reduce the need for invasive biopsy in certain contexts.
Historical Context
The clinical utility of peripheral nerve biopsy was first recognized in the mid‑20th century, notably for the diagnosis of leprosy and vasculitic neuropathy. Over subsequent decades, refinements in surgical technique and neuropathologic methods have expanded its role in modern neurology and pathology.
See also
- Peripheral neuropathy
- Nerve conduction study
- Sural nerve
- Neuropathology
- Vasculitis
References
(References are omitted in this summary but would typically include peer‑reviewed journals, clinical practice guidelines, and standard textbooks on neurology and neuropathology.)